This article is available to subscribers. Subscribe now. Already have an account? Sign in

Original ArticleFree PreviewArchive

Molecular Analysis of the T(14;18) Chromosomal Translocation in Malignant Lymphomas

List of authors.
  • Lawrence M. Weiss, M.D.,
  • Roger A. Warnke, M.D.,
  • Jeffrey Sklar, M.D.,
  • and Michael L. Cleary, M.D.

Abstract

One of the most common karyotypic abnormalities is the t(14;18) translocation, which is found in many lymphomas that have a characteristic follicular morphology. Recent molecular studies have shown that this chromosomal translocation results in the juxtaposition of the candidate proto-oncogene bcl-2 (B-cell leukemia–lymphoma) on chromosome 18 with the immunoglobulin heavy-chain locus on chromosome 14. However, because performing accurate cytogenetic studies in solid hematolymphoid neoplasms is difficult, knowledge of the prevalence of the t(14;18) translocation and, by association, the extent of bcl-2 involvement in human lymphomas is limited.

We used a number of chromosome-18 DNA probes to analyze various subtypes of Hodgkin's and non-Hodgkin's lymphomas and test for structural abnormalities near or within the bcl-2 gene. Molecular features of the t(14;18) translocation were found in virtually all follicular neoplasms and about 28 percent of diffuse large-cell lymphomas. No changes in bcl-2 were found in several other subtypes of Hodgkin's and non-Hodgkin's lymphomas, including those previously suggested to originate from follicular-center cells and those about which cytogenetic data have been difficult to obtain. Our findings suggest a close pathogenetic relation between bcl-2 and a large group of non-Hodgkin's lymphomas, both with and without a follicular morphology. The methods employed in this study may be useful in improving the accuracy of diagnosis and subclassification of malignant lymphomas. (N Engl J Med 1987; 317:1185–9.)

Funding and Disclosures

Supported in part by grants (CA-34233, CA-38621, and CA-42971) from the National Institutes of Health, and by a grant from the Lucille P. Markey Charitable Trust. Dr. Weiss is a Hume Faculty Scholar, and Dr. Cleary is a scholar of the Lucille P. Markey Charitable Trust.

Author Affiliations

From the Laboratory of Experimental Oncology, Department of Pathology, Stanford University School of Medicine, Stanford, CA 94305, where reprint requests should be addressed to Dr. Cleary.

Print Subscriber? Activate your online access.